Articles

Search all Cancer Immunology, Immunotherapy articles

Filter by

Volume:

Sort by

Date published:

New to old Old to new

Showing 1-50 of 6,746 articles

Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study
Jhe-Cyuan Guo
Ta-Chen Huang
Chih-Hung Hsu
Research Open access 09 September 2024 Article: 230
Secretome and immune cell attraction analysis of head and neck cancers
Tara Muijlwijk
Niels E. Wondergem
Rieneke van de Ven
Research Open access 09 September 2024 Article: 229
Disruptions in antigen processing and presentation machinery on sarcoma
Salvatore Lorenzo Renne
Laura Sama’
Ferdinando Carlo Maria Cananzi
Research Open access 09 September 2024 Article: 228
Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic ductal adenocarcinoma
Shih-Hung Yang
Sung-Hsin Kuo
Kun-Huei Yeh
Research Open access 09 September 2024 Article: 227
Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents
Dingyi Yang
Erha Munai
Xiao-Dong Zhu
Research Open access 06 September 2024 Article: 226
Impaired TGF-β signaling via AHNAK family mutations elicits an esophageal cancer subtype with sensitivities to genotoxic therapy and immunotherapy
Zihang Mai
Kongjia Luo
Jianhua Fu
Research Open access 05 September 2024 Article: 225
Correction to: Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells
Ibrahim El-Seraf
Isabella Micallef Nilsson
Isabelle Magalhaes
Correction Open access 05 September 2024 Article: 224
Distribution characteristics of immune infiltration and lymphovascular invasion in patients with breast cancer skin recurrence
Danyang Zhou
Mei Li
Ruoxi Hong
Research Open access 05 September 2024 Article: 223
A comprehensive and longitudinal evaluation of the different populations of lymphoid and myeloid cells in the peripheral blood of patients treated with chemoradiotherapy for head and neck cancer
Jens von der Grün
Martina Broglie
Panagiotis Balermpas
Research Open access 05 September 2024 Article: 222
Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma
Colin H. Quinn
Janet R. Julson
Elizabeth A. Beierle
Research Open access 05 September 2024 Article: 221
Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration
Yunxin Lu
Yin Jin
Dongsheng Zhang
Research Open access 05 September 2024 Article: 220
SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer
Jin Li
Yuxian Bai
Shukui Qin
Research Open access 05 September 2024 Article: 219
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
Sarah M. Zimmerman
Erin Suh
George P. Souroullas
Brief Report Open access 05 September 2024 Article: 218
Immunogenomic features of radiologically distinctive nodules in multiple primary lung cancer
Mei-Cheng Chen
Hao-Shuai Yang
Ying Zhu
Research Open access 05 September 2024 Article: 217
The short-term efficacy of neoadjuvant SOX versus SOX plus immune checkpoint inhibitor following laparoscopic gastrectomy for locally advanced gastric cancer: a multicenter retrospective cohort study in China
Hao Cui
Yongpu Yang
Bo Wei
Research Open access 05 September 2024 Article: 216
Immune microenvironmental heterogeneity according to tumor DNA methylation phenotypes in microsatellite instability-high colorectal cancers
Jung Ho Kim
Jiyun Hong
Sangwoo Kim
Research Open access 05 September 2024 Article: 215
Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapy
Daiki Murata
Koichi Azuma
Tomoaki Hoshino
Research Open access 05 September 2024 Article: 214
High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinoma
Samuel L. Hill
Gessa Sugiyarto
Tim Elliott
Brief Report Open access 05 September 2024 Article: 213
Increasing monocytes after lung cancer surgery triggers the outgrowth of distant metastases, causing recurrence
Yo Kawaguchi
Keigo Okamoto
Jun Hanaoka
Research Open access 05 September 2024 Article: 212
Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities
Ryota Kikuchi
Yusuke Watanabe
Shinji Abe
Research Open access 05 September 2024 Article: 211
Part of 1 collection:

Adverse Drug Reactions in Immunotherapy: Safety and Management
Preclinical development of a novel CCR8/CTLA-4 bispecific antibody for cancer treatment by disrupting CTLA-4 signaling on CD8 T cells and specifically depleting tumor-resident Tregs
Cuicui Guo
Xiaodong Dai
Xun Gui
Research Open access 09 August 2024 Article: 210
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Aurelie Herault
Judy Mak
Kevin B. Walsh
Research Open access 08 August 2024 Article: 209
DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancer
Yesiboli Tasiheng
Xuan Lin
Chen Liu
Research Open access 07 August 2024 Article: 208
Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinoma
Wenjing Li
Jianqing You
Changping Wu
Research Open access 06 August 2024 Article: 207
Deciphering the interplay of HPV infection, MHC-II expression, and CXCL13⁺ CD4⁺ T cell activation in oropharyngeal cancer: implications for immunotherapy
Shida Yan
Xing Zhang
Ming Song
Research Open access 06 August 2024 Article: 206
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors
Ravit Geva
Maria Vieito
Victor Moreno
Research Open access 06 August 2024 Article: 205
Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature
Haonan Xu
Shannon Nicole Russell
Keaton Ian Jones
Review Open access 06 August 2024 Article: 204
Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy
Rong Duan
Philip Milton
Zhenqiang Yao
Research Open access 06 August 2024 Article: 203
Impact of the interval between neoadjuvant immunotherapy and surgery on prognosis in esophageal squamous cell carcinoma (ESCC): a real-world study
Guozhen Yang
Yutong Hong
Xu Zhang
Research Open access 06 August 2024 Article: 202
Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic cancer: a single-arm, phase II clinical trial
Qin Wang
Fan Tong
Juan Du
Research Open access 06 August 2024 Article: 201
Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series
Ramya Muddasani
Neel Talwar
Ravi Salgia
Brief Report Open access 06 August 2024 Article: 200
Part of 1 collection:

Adverse Drug Reactions in Immunotherapy: Safety and Management
Anlotinib reversed resistance to PD-1 inhibitors in recurrent and metastatic head and neck cancers: a real-world retrospective study
Jianyun Jiang
Bin Wu
Zuguang Xia
Research Open access 06 August 2024 Article: 199
CD27 signaling inhibits tumor growth and metastasis via CD8 + T cell-independent mechanisms in the B16-F10 melanoma model
Eswara Rao Puppala
Long Wu
Xuefang Cao
Research Open access 06 August 2024 Article: 198
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer
Changhee Park
Koung Jin Suh
Jee Hyun Kim
Research Open access 06 August 2024 Article: 197
The expression of PD-L1 on tumor-derived exosomes enhances infiltration and anti-tumor activity of αCD3 × αPD-L1 bispecific antibody-armed T cells
Jaewon Cho
Nara Tae
Hyun-Jeong Ko
Research Open access 06 August 2024 Article: 196
Part of 1 collection:

Combinatorial approaches for cancer immunotherapy
Conversion of anti-tissue factor antibody sequences to chimeric antigen receptor and bi-specific T-cell engager format
S. C. Saunderson
J. C. Halpin
A. D. McLellan
Research Open access 06 August 2024 Article: 195
First-line treatment with KN046, chemotherapy and palliative radiotherapy for advanced esophageal squamous cell carcinoma: an open-label, dose escalation, and dose expansion phase Ib trial
Qi Zhao
Xi Su
Songbing Qin
Research Open access 06 August 2024 Article: 194
Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis
Guangzhong Guo
Ziyue Zhang
Xingyao Bu
Research Open access 06 August 2024 Article: 193
Part of 1 collection:

Adverse Drug Reactions in Immunotherapy: Safety and Management
TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3
Oscar Perales
Lucia Jilaveanu
David A. Schoenfeld
Brief Report Open access 06 August 2024 Article: 192
GP100 expression is variable in intensity in melanoma
Jacqueline E. Mann
Nitzan Hasson
Harriet M. Kluger
Brief Report Open access 06 August 2024 Article: 191
ALK5/VEGFR2 dual inhibitor TU2218 alone or in combination with immune checkpoint inhibitors enhances immune-mediated antitumor effects
Nam-Hoon Kim
Jihyun Lee
Hun-Taek Kim
Research Open access 06 August 2024 Article: 190
Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer
Siqi Cai
Guanqun Yang
Xiaorong Sun
Research Open access 02 August 2024 Article: 189
Part of 1 collection:

Regulatory T cells in cancer immunosuppression
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Huantong Wu
Zhuofan Xu
Zan Chen
Research Open access 02 August 2024 Article: 188
Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq
Yan Tian
Chao Liu
Shikai Wu
Research Open access 02 August 2024 Article: 187
Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent
Víctor Albarrán
Patricia Guerrero
Pablo Gajate
Research Open access 02 August 2024 Article: 186
Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ≥ 75 years: results of a real-world cohort including 456 patients
A. Gawaz
I. Wolff
A. Forschner
Research Open access 05 July 2024 Article: 185
Part of 1 collection:

Adverse Drug Reactions in Immunotherapy: Safety and Management
Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo
Iga Jancewicz
Magdalena Śmiech
Pawel Wisniewski
Correction Open access 05 July 2024 Article: 184
Correction to: The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy
Wenxin Lu
Guangyu Wu
Liwei Wang
Correction Open access 05 July 2024 Article: 183
Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers
Zhenghang Wang
Siyuan Cheng
Jian Li
Research Open access 05 July 2024 Article: 182
In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patients
Laura M. Timmerman
Lobke C. M. Hensen
the UNICIT consortium
Research Open access 05 July 2024 Article: 181

1
2
…
135
Next page